Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q53408442)
Watch
English
Bapineuzumab in Alzheimer's disease: where now?
scientific article
In more languages
default values for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20129159
retrieved
14 May 2018
reference URL
http://europepmc.org/abstract/MED/20129159
title
Bapineuzumab in Alzheimer's disease: where now?
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20129159
retrieved
14 May 2018
reference URL
http://europepmc.org/abstract/MED/20129159
main subject
Alzheimer's disease
0 references
author name string
Gordon K Wilcock
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20129159
retrieved
14 May 2018
reference URL
http://europepmc.org/abstract/MED/20129159
publication date
1 February 2010
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20129159
retrieved
14 May 2018
reference URL
http://europepmc.org/abstract/MED/20129159
published in
Lancet Neurology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20129159
retrieved
14 May 2018
reference URL
http://europepmc.org/abstract/MED/20129159
volume
9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20129159
retrieved
14 May 2018
reference URL
http://europepmc.org/abstract/MED/20129159
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20129159
retrieved
14 May 2018
reference URL
http://europepmc.org/abstract/MED/20129159
page(s)
134-136
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20129159
retrieved
14 May 2018
reference URL
http://europepmc.org/abstract/MED/20129159
cites work
Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970359-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970359-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970359-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970359-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2809%2970359-X
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1474-4422(09)70359-X
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20129159
retrieved
14 May 2018
reference URL
http://europepmc.org/abstract/MED/20129159
PubMed publication ID
20129159
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20129159
retrieved
14 May 2018
reference URL
http://europepmc.org/abstract/MED/20129159
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
